Long-term risks of invasive cervical cancer following HPV infection: follow-up of two screening cohorts in Manchester
Name:
36959379.pdf
Size:
589.2Kb
Format:
PDF
Description:
Identified with Open Access button
Affiliation
London School of Hygiene & Tropical Medicine, London, UK.Issue Date
2023
Metadata
Show full item recordAbstract
Background: Long-term follow-up of large cohorts is needed to determine the effects of HPV and screening on CIN3 (grade 3 cervical intraepithelial neoplasia) and ICC (invasive cervical cancer). Methods: Women were recruited when attending for routine cervical screening in Greater Manchester, UK: 1987-93 for the Manchester Cohort (MC: 47,625 women) and 2001-03 for the ARTISTIC Cohort (AC: 24,496 women). Both were followed through national registration for cancer incidence and mortality to 2020. Results: Risk patterns following HPV infection differed for CIN3 and ICC. Risk of ICC in the MC rises for 30 years following a single positive HPV test, reaching 2.5% (95% CI: 1.3-4.5%). A similar pattern was seen in the AC, but the risks of cancer were approximately halved. CIN3 was diagnosed much sooner in the AC due to more efficient cytology. More sensitive HPV testing was able to better predict future risk. Conclusion: The sensitivity of HPV testing and cytology influences the CIN3 detection rate. Sensitive HPV testing enables effective risk stratification. Increased risk of ICC is observed 15-30 years after HPV infection. Women testing HPV + should be followed until their infection clears. Discharging women from screening programmes whilst they remain HPV + may not be safe, even if cytology and colposcopy tests are normal.Citation
Gilham C, Sargent A, Crosbie EJ, Peto J. Long-term risks of invasive cervical cancer following HPV infection: follow-up of two screening cohorts in Manchester. British journal of cancer. 2023 Mar 23. PubMed PMID: 36959379. Epub 2023/03/25. eng.Journal
British Journal of CancerDOI
10.1038/s41416-023-02227-9PubMed ID
36959379Additional Links
https://dx.doi.org/10.1038/s41416-023-02227-9Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1038/s41416-023-02227-9
Scopus Count
Collections
Related articles
- HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
- Authors: Gilham C, Sargent A, Kitchener HC, Peto J
- Issue date: 2019 Jun
- The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
- Authors: C Kitchener H, Canfell K, Gilham C, Sargent A, Roberts C, Desai M, Peto J
- Issue date: 2014 Apr
- Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
- Authors: Castle PE, Stoler MH, Wright TC Jr, Sharma A, Wright TL, Behrens CM
- Issue date: 2011 Sep
- Triaging women with human papillomavirus infection and normal cytology or low-grade dyskaryosis: evidence from 10-year follow up of the ARTISTIC trial cohort.
- Authors: Gilham C, Sargent A, Peto J
- Issue date: 2020 Jan
- Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening.
- Authors: Naucler P, Ryd W, Törnberg S, Strand A, Wadell G, Elfgren K, Rådberg T, Strander B, Forslund O, Hansson BG, Hagmar B, Johansson B, Rylander E, Dillner J
- Issue date: 2009 Jan 21